Ron Andrews Answers the Question “Is My Cancer Different?”

Ron Andrews, CEO of Clarient talks about the launch of GE’s cancer patient advocacy campaign and how molecular pathology advances are being used to develop new cancer treatments.

Share

Comments

comments

Powered by Facebook Comments

Comments are closed.